|
Cook ireland ltd (manufacturer) is submitting this report on behalf of cook medical incorporated (cmi)(importer).Exemption number: e2016031.Information pertaining to section g.1 as follows: importer site contact and address: (b)(4) cook medical incorporated (cmi) 1025 acuff road p.O box 4195 bloomington indiana 47402-4195.Importer site establishment registration number: 3005580113.The flaps in the stent were not open enough and it was difficult to use of rpn: gpso-10-10¿ geenen pancreatic stent from lot # cf1536312.The event occurred on 02-oct-2018, the stent was placed in the pancreatic duct as it was intended and the patient did not required additional procedures or suffer any adverse effects.This event occurred during use.This file is related to the migration of the stent during placement.An additional file relates to the flat flaps complaint.The device will not be returned, no photos will be sent of the device.The device was used in the procedure.The investigation will take place with limited information.1 x gpso-10-10 of lot number cf1536312 was not returned to cirl for an evaluation therefore a documentation based investigation was completed.The complaint is confirmed based on customer testimony.3.Root cause (possible): a definitive root cause for the customer complaint could not be determined as the exact operational conditions of use could not be replicated in the laboratory setting as the device was not returned.4.Documents review: a review of the manufacturing records for the gpso-10-10 device of lot # cf1536312 involved in this complaint did not reveal any discrepancies that could have contributed to the complaint issue.There is no evidence to suggest that this issue affects the entire lot # cf1536312; upon review of complaints this failure mode has not occurred previously with this lot # cf1536312.Prior to distribution all gpso-10-10¿ geenen pancreatic stent devices are subject to visual inspection to ensure device integrity.These inspection checks are outlined in internal procedures in place at cirl the instructions for use, ifu (ifu0055-3) which accompanies this device instructs the end user ¿visually inspect with particular attention to kinks, bends and breaks.If an abnormality is detected that would prohibit proper working condition, do not use.¿ additional in the instructions for use, ifu (ifu0055-3) instructs the end user in step 1.¿gently ensure full extension of all flaps¿ and step 6.¿ after confirming stent position, gently remove wire guide, then the guiding catheter from endoscope while maintaining position of stent with pushing catheter.¿ there is no evidence to suggest the user did not follow the instructions for use for this device.The stent was repositioned and the flaps opened against papilla and stent was left in the pancreatic duct.Summary: 1.Customer complaint is confirmed based on the customer¿s testimony.2.The patient didn¿t experience any adverse effects as result of the device failure.3.Complaints of this nature will continue to be monitored for potential emerging trends.
|
|
Additional information received on the 11-oct-18 confirming that the stent migrated.This file is being reported based on the fda mdr malfunction "stent migration" as per problem statement: (b)(6) from the hospital emailed about problems with 2 pancreatic stents.Rep will confirm the correct rpn and lot after visiting the hospital tomorrow.The flaps in the stent were not open enough and it was difficult to use them.They had this issue with 2 patients, but they were able to use the stents.Not available for return."as per complaint form": the stent was left in the pancreatic duct as it was intended.Endoscopic pancreatic stenting procedure.Stent's flaps were so flat that the stent migrated in, and it had to be manipulated several times.Finally flap opened against papilla and stent was left in the pancreatic duct.
|